SCHEMBL2650993

SCHEMBL2650993

c1cn2cnncc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88351 0.70
SCHEMBL64580 0.65
SCHEMBL665488 0.65
SCHEMBL2629380 0.65 TGFBR1 (0.43)
SCHEMBL2659263 0.65 L3MBTL1 (0.37)
SCHEMBL25158171 0.64 DYRK1A (0.37)
SCHEMBL23697854 0.64 PIK3C3 (0.35)
SCHEMBL557100 0.64 ABL1 (0.36)
SCHEMBL5487376 0.64 DYRK1A (0.40)
SCHEMBL11266549 0.64 DYRK1A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0185345-A1 Imidazo derivatives, their preparation and medicines containing them Dr. Karl Thomae GmbH (DE) 1986-06-25 EP claimed
WO-2025153624-A1 IMIDAZO[1,2-D][1,2,4]TRIAZINE DERIVATIVES FOR USE AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY AC IMMUNE SA (CH) 2025-07-24 WO disclosed
WO-2025153625-A1 IMIDAZO[1,2-D][1,2,4]TRIAZINE DERIVATIVES FOR USE AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY AC IMMUNE SA (CH) 2025-07-24 WO disclosed
EP-4219465-A2 PRMT5 INHIBITORS AND USES THEREOF Epizyme Inc (US) 2023-08-02 EP disclosed
EP-3498701-B1 PRMT5 INHIBITORS AND USES THEREOF EPIZYME INC (US) 2023-02-22 EP disclosed
WO-2022135365-A1 DISUBSTITUTED CYCLOPENTANE KINASE INHIBITORS ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) 2022-06-30 WO disclosed
US-11185531-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2021-11-30 US disclosed
US-10800743-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2020-10-13 US disclosed
EP-2970132-B1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF EPIZYME INC (US) 2020-09-23 EP disclosed
US-20200289469-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. 2020-09-17 US disclosed
EP-1212324-B1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME (GB) 2003-10-29 EP disclosed
US-6608062-B1 Ligands for gamma-aminobutyric acid receptors; treatment and/or prevention of central nervous system disorders, including anxiety MERCK SHARP & DOHME LTD. 2003-08-19 US disclosed
EP-1212324-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP &amp; DOHME LTD. (GB) 2002-06-12 EP disclosed
EP-1212324-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP &amp; DOHME LTD. (GB) 2002-06-12 EP disclosed
WO-2001014377-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-03-01 WO disclosed
WO-2001014377-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-03-01 WO disclosed
EP-0713876-A1 Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor Wakamoto Pharmaceutical Co., Ltd. (JP) 1996-05-29 EP disclosed
US-4716169-A INOTROPIC AGENTS DR. KARL THOMAE GMBH (DE) 1987-12-29 US disclosed
EP-0185345-A1 Imidazo derivatives, their preparation and medicines containing them Dr. Karl Thomae GmbH (DE) 1986-06-25 EP disclosed
US-4107309-A ANTIASTHMATIC AGENTS, ENZYME INHIBITORS, REACTING A THIONE WITH SODIUM ETHOXIDE AND METHYL IODIDE AMERICAN CYANAMID COMPANY (US) 1978-08-15 US disclosed